{"id":"NCT03519386","sponsor":"Glaukos Corporation","briefTitle":"Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%","officialTitle":"Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-07-26","primaryCompletion":"2022-04-05","completion":"2024-04-02","firstPosted":"2018-05-09","resultsPosted":"2023-09-14","lastUpdate":"2024-11-29"},"enrollment":590,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Glaucoma, Open-Angle","Ocular Hypertension"],"interventions":[{"type":"COMBINATION_PRODUCT","name":"G2-TR intraocular implant containing travoprost","otherNames":["Implant Group"]},{"type":"DRUG","name":"Sham surgery + active-comparator eye drops","otherNames":["Control Group"]}],"arms":[{"label":"Implant Group 1","type":"EXPERIMENTAL"},{"label":"Implant Group 2","type":"EXPERIMENTAL"},{"label":"Control Group","type":"ACTIVE_COMPARATOR"}],"summary":"Phase III study to compare the safety and efficacy of intraocular implants containing travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, 0.5% (timolol) in reducing elevated intraocular pressure in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).","primaryOutcome":{"measure":"Change From Baseline in Diurnal IOP (as Measured at 8AM and 10AM) Through 3 Months Postoperative","timeFrame":"3 months","effectByArm":[{"arm":"Implant Group 1","deltaMin":-8.4,"sd":0.24},{"arm":"Implant Group 2","deltaMin":-8.48,"sd":0.24},{"arm":"Control Group","deltaMin":-7.69,"sd":0.24}],"pValues":[{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["39240530","38985408","38345710","35076329"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":200},"commonTop":["intraocular pressure increased","iritis"]}}